FDA Approves Augtyro for NTRK-Positive Advanced Solid Tumors
Approval is for both TKI-naive and TKI-pretreated patients across solid tumor types
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Approval is for both TKI-naive and TKI-pretreated patients across solid tumor types
Only registered members have full access to PracticeUpdate content.